According to the enrichment analysis of the PPI network and KEGG pathway, TY ameliorates RA by regulating PI3K/AKT, MAPK and other signaling pathways through key targets such as AKT1, TNF, IL‐6, VEGFA, and IL‐1β. The gene discussed is AKT1; the disease is rheumatoid arthritis.